Cover Image
市場調查報告書

MediPoint:超音波影像診斷 - 美國市場的分析與預測

MediPoint: Diagnostic Ultrasound Imaging - US Analysis and Market Forecasts

出版商 GlobalData 商品編碼 295036
出版日期 內容資訊 英文 184 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:超音波影像診斷 - 美國市場的分析與預測 MediPoint: Diagnostic Ultrasound Imaging - US Analysis and Market Forecasts
出版日期: 2014年01月31日 內容資訊: 英文 184 Pages
簡介

要提高存活率,就要早期診斷出疾病。超音波影像診斷是最普遍用來達成成人和兒童患者的早期發現臨床性評估的技術,並成為疾病管理的基礎。

本報告提供美國的超音波影像診斷市場調查分析,提供超音波設備的未滿足需求,醫生的想法,驗證迅速的技術進步所帶來的超音波影像診斷的未來性,再加上主要企業簡介,市場預測等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 超音波影像診斷的原理
  • 系統概要
  • 運轉方式
  • 超音波影像的應用
  • 超音波影像診斷的優點和缺點
  • 市場進入
  • 品牌忠誠
  • 新技術的引進
  • 法規流程
  • 目前給付趨勢
  • 治療趨勢
  • 技術的演進
  • 超音波影像的過度利用
  • M&A,主要的夥伴關係
  • 法規的問題/產品回收

第4章 未滿足需求分析

  • 概要
  • 設備的改良
  • 設備的偏差
  • 依然依賴工程師

第5章 市場機會分析

  • 造影式超音波影像
  • 小型化,智慧化
  • 新興技術投資
  • 最新的應用
  • 融合影像

第6章 推動市場要素和機會

  • 概要
  • 推動因素
  • 障礙

第7章 競爭評估

  • 概要
  • 依功能分類
  • 依價格分類

第8章 開發平台評估

  • 概要
  • Flash Ultrasound(InnerVision Medical Technologies)
  • Sonic Window(Analogic)
  • Breast Histoscanning(Advanced Medical Diagnostics)
  • ImagistxProstate(Imagistx)
  • Breast Imaging Ultrasound System(Sonarium Medical)
  • SoftVue(Delphinus Medical Technologies)

第9章 現在/未來的主要企業

  • 概要
  • 企業策略趨勢
  • 前幾名企業
  • 企業簡介(概要,投資組合,SWOT分析)
    • GE Healthcare
    • Siemens
    • Philips
    • Esaote
    • Analogic
    • 東芝MedicalSystems
    • Mindray Medical International
    • 日立ALOKA醫學
    • FUJIFILM Holdings
    • Samsung Medison
    • Terason
    • SuperSonic Imagine
    • 其他的企業

第10章 市場預測

  • 企業的市場佔有率
  • 市場部門別

第11章 附錄

圖表

目錄
Product Code: GDME1080CFR

An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic ultrasound imaging market in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this ultrasound systems market. This report also discusses physician attitudes towards current diagnostic ultrasound techniques, and the future of diagnostic ultrasound imaging in the face of rapid technological advancements.

As with other developed countries, the US offers better access to healthcare and has higher utilization rates of imaging technologies than some developing countries. US procedure volumes are also being driven by both technological advancement and the growing baby boomer population.

Scope

  • An overview of Diagnostic ultrasound imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the US Diagnostic ultrasound imaging market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.
  • Investigation of current and future market competition for Diagnostic ultrasound imaging.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Diagnostic ultrasound imaging sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL)

Reasons to buy

  • Understand the trends shaping and driving the US Diagnostic ultrasound imaging Market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the US Diagnostic ultrasound imaging market through 2019.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the US Diagnostic ultrasound imaging market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Principle of Diagnostic Ultrasound Imaging
  • 3.2. System Overview
  • 3.3. Modes of Operation
    • 3.3.1. A-Mode
    • 3.3.2. B-Mode
    • 3.3.3. M-Mode
    • 3.3.4. Doppler Mode
    • 3.3.5. 3D Ultrasound/4D Ultrasound
  • 3.4. Applications of Ultrasound Imaging
    • 3.4.1. Overview
    • 3.4.2. Obstetrics and Gynecology
    • 3.4.3. Abdominal Examinations
    • 3.4.4. Cardiovascular Examinations
    • 3.4.5. Neurology
    • 3.4.6. Musculoskeletal
    • 3.4.7. Small Body Parts
  • 3.5. Advantages and Disadvantages of Diagnostic Ultrasound
    • 3.5.1. Overview
    • 3.5.2 SWOT Analysis
  • 3.6 Market Access
    • 3.6.1. Product Life Cycle
    • 3.6.2. Purchasing Decisions
  • 3.7. Brand Loyalty
  • 3.8. Adoption of New Technologies
    • 3.8.1. Influence of Clinical Trials Results
    • 3.8.2. Reimbursement
  • 3.9. Regulatory Process
    • 3.9.1. US
  • 3.10. Current Reimbursement Trends
  • 3.11. Procedure Trends
    • 3.11.1. Overview
    • 3.11.2. US
  • 3.12. Evolution in Technology
    • 3.12.1. Plane-Wave Imaging
    • 3.12.2. Transducer Technology
  • 3.13. Overuse of Ultrasound Imaging
  • 3.14. M&A, Key Partnerships
  • 3.15. Regulatory Issues/Product Recalls

4. Unmet Needs Analysis

  • 4.1. Overview
  • 4.2. Instrumentation Improvement
  • 4.3. Inter-Instrument Variability
  • 4.4. Ultrasound Remains Significantly Operator-Dependent

5. Market Opportunity Analysis

  • 5.1. Contrast Ultrasound Imaging to Foster Growth
  • 5.2. Ultrasound Imaging Set to Get Smaller and Smarter
  • 5.3. Invest in Emerging Technologies
  • 5.4. Newer Applications for Diagnostic Ultrasound on the Horizon
  • 5.5. Fusion Imaging

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Rising Prevalence of Diseases
  • 6.3. Driver: Increased Demand for Cost-Effective Quality Healthcare
  • 6.4. Driver: Newer Technologies to Drive the Growth of the Market
  • 6.5. Driver: Increased Consciousness Regarding Radiation Dose
  • 6.6. Driver: Compact Systems to Drive Growth
  • 6.7. Driver: Expanding Use of Ultrasound by Non-Radiologists
  • 6.8. Driver: Steady Reimbursement
  • 6.9. Driver: Population-Based Screening Applications Using Diagnostic Ultrasound
  • 6.10. Barrier: Shortage of Dedicated Ultrasound Technologists
  • 6.11. Barrier: Less Monetary Incentive to use Ultrasound in Comparison with Other Techniques
  • 6.12. Barrier: Lifestyle-Related Diseases May Tip the Scales
  • 6.13. Barrier: Reduced Hospital Budgets
  • 6.14. Barrier: Medical Device Excise Tax
  • 6.15. Barrier: Availability of Venture Capital

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Classification Based on Features
    • 7.2.1. Black and White Ultrasound Imaging Systems
    • 7.2.2. Color Ultrasound Imaging Systems
  • 7.3. Classification Based on Price
    • 7.3.1. Premium Ultrasound Systems
    • 7.3.2. High-End Systems
    • 7.3.3. Mid-Range Systems
    • 7.3.4. Low-End Systems
    • 7.3.5. Point-of-Care Systems

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Flash Ultrasound (InnerVision Medical Technologies)
    • 8.2.1. Overview
    • 8.2.2. SWOT Analysis
  • 8.3. Sonic Window (Analogic)
    • 8.3.1. Overview
    • 8.3.2. SWOT Analysis
  • 8.4. Breast Histoscanning (Advanced Medical Diagnostics)
    • 8.4.1. Overview
    • 8.4.2. SWOT Analysis
  • 8.5. ImagistxProstate (Imagistx)
    • 8.5.1. Overview
    • 8.5.2. SWOT Analysis
  • 8.6. Breast Imaging Ultrasound System (Sonarium Medical)
    • 8.6.1. Overview
    • 8.6.2. SWOT Analysis
  • 8.7. SoftVue (Delphinus Medical Technologies)
    • 8.7.1. Overview
    • 8.7.2. SWOT Analysis

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Trends in Corporate Strategy
  • 9.3. Who Is On Top?
  • 9.4. GE Healthcare
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Siemens
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. Philips
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Esaote
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Analogic
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Toshiba Medical Systems
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Mindray Medical International
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Hitachi Aloka Medical
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Fujifilm Holdings
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Samsung Medison
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Terason
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. SuperSonic Imagine
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Other Companies

10. Market Outlook

  • 10.1. Company Market Share
  • 10.2. By Market Segment
    • 10.2.1. Overview
    • 10.2.2. Portable Black and White Systems
    • 10.2.3. Stand-Alone Black and White Systems
    • 10.2.4. Portable Color Systems
    • 10.2.5. Stand-Alone Color Systems

11. Appendix

  • 11.1. Bibliography
  • 11.2. Definitions
  • 11.3. Abbreviations
  • 11.4. Research Methodology
    • 11.4.1. Overview
    • 11.4.2. Coverage
    • 11.4.3. Secondary Research
  • 11.5. Physicians and Specialists Included in this Study
  • 11.6. Primary Research
    • 11.6.1. Primary Research - Key Opinion Leader Interviews
    • 11.6.2. Expert Panel Validation
    • 11.6.3. Stakeholder Survey
  • 11.7. Forecasting Methodology
  • 11.8. About the Authors
    • 11.8.1. Analysts
    • 11.8.2. Global Head of Healthcare
  • 11.9. About GlobalData
  • 11.10. Disclaimer

List of Tables

  • Table 1: Advantages and Disadvantages of Ultrasound Imaging, 2013
  • Table 2: Ultrasound Imaging SWOT Analysis, 2013
  • Table 3: Diagnostic Ultrasound Procedures in the US (m), 2010-2019
  • Table 4: Other Key Events in the Diagnostic Ultrasound Market
  • Table 5: Diagnostic Ultrasound Market - Drivers and Barriers, 2013
  • Table 6: Portable Black and White Systems
  • Table 7: Stand-Alone Black and White Systems
  • Table 8: Black and White Ultrasound Systems SWOT Analysis, 2013
  • Table 9: Portable Color Ultrasound Systems
  • Table 10: Stand-Alone Color Ultrasound Systems
  • Table 11: Color Ultrasound Systems SWOT Analysis, 2013
  • Table 12: Premium Ultrasound Systems
  • Table 13: Premium Ultrasound Systems SWOT Analysis, 2013
  • Table 14: High-End Ultrasound Systems
  • Table 15: High-End Ultrasound Systems SWOT Analysis, 2013
  • Table 16: Mid-Range Ultrasound Systems
  • Table 17: Mid-Range Ultrasound Systems SWOT Analysis, 2013
  • Table 18: Low-End Ultrasound Systems
  • Table 19: Low-End Ultrasound Systems SWOT Analysis, 2013
  • Table 20: Point-of-Care Ultrasound Systems
  • Table 21: POC Ultrasound Systems SWOT Analysis, 2013
  • Table 22: Flash Ultrasound SWOT Analysis, 2013
  • Table 23: Sonic Window SWOT Analysis, 2013
  • Table 24: Breast Histoscanning SWOT Analysis, 2013
  • Table 25: ImagistxProstate SWOT Analysis, 2013
  • Table 26: Breast Imaging Ultrasound System SWOT Analysis, 2013
  • Table 27: SoftVue SWOT Analysis, 2013
  • Table 28: GE Healthcare Portfolio Assessment, 2013
  • Table 29: GE Healthcare SWOT Analysis, 2013
  • Table 30: Siemens Healthcare Portfolio Assessment, 2013
  • Table 31: Siemens Healthcare SWOT Analysis, 2013
  • Table 32: Philips Healthcare, Ultrasound Systems, Marketed Products
  • Table 33: Philips Healthcare SWOT Analysis, 2013
  • Table 34: Esaote Portfolio Assessment, 2013
  • Table 35: Esaote SWOT Analysis, 2013
  • Table 36: Analogic Portfolio Assessment, 2013
  • Table 37: Analogic SWOT Analysis, 2013
  • Table 38: Toshiba Medical Systems, Portfolio Assessment, 2013
  • Table 39: Toshiba Medical Systems SWOT Analysis, 2013
  • Table 40: Mindray Medical International, Portfolio Assessment, 2013
  • Table 41: Mindray Medical International SWOT Analysis, 2013
  • Table 42: Hitachi Aloka Medical Portfolio Assessment, 2013
  • Table 43: Hitachi Aloka Medical SWOT Analysis, 2013
  • Table 44: Fujifilm Holdings Portfolio Assessment, 2013
  • Table 45: Fujifilm Holdings SWOT Analysis, 2013
  • Table 46: Samsung Medison Portfolio Assessment, 2013
  • Table 47: Samsung Medison SWOT Analysis, 2013
  • Table 48: Terason Portfolio Assessment, 2013
  • Table 49: Terason SWOT Analysis, 2013
  • Table 50: SuperSonic Imagine Portfolio Assessment, 2013
  • Table 51: SuperSonic Imagine SWOT Analysis, 2013
  • Table 52: Other Companies in the Diagnostic Ultrasound Imaging Market, 2013
  • Table 53: US Diagnostic Ultrasound Sales Forecast by Segment, 2010-2019
  • Table 54: Total Installed Base and Unit Sales of Ultrasound Systems in the US, 2010-2019
  • Table 55: Installed Base and Unit Sales of Black and White Ultrasound Systems in the US, 2010-2019
  • Table 56: Installed Base and Unit Sales of Color Ultrasound Systems in the US, 2010-2019
  • Table 57: Change in Average Selling Price in the US, 2010-2019
  • Table 58: Company Market Share, US, 2012
  • Table 59: US Diagnostic Ultrasound Sales Forecast, Portable Black and White Systems, 2010-2019
  • Table 60: US Diagnostic Ultrasound Sales Forecast, Stand-Alone Black and White Systems, 2010-2019
  • Table 61: US Diagnostic Ultrasound Sales Forecast, Portable Color Systems, 2010-2019
  • Table 62: US Diagnostic Ultrasound Sales Forecast, Stand-Alone Color Systems, 2010-2019
  • Table 63: Primary Research Summary
  • Table 64: Primary Research Participants Affiliation

List of Figures

  • Figure 1: Ultrasound Imaging
  • Figure 2: Ultrasound Depth vs. Resolution
  • Figure 3: A-Mode Ultrasound Image
  • Figure 4: B-Mode Ultrasound Image
  • Figure 5: M-Mode Ultrasound Image
  • Figure 6: Color Doppler Mode Ultrasound Image
  • Figure 7: 3D Ultrasound Image
  • Figure 8: Procedure Trends for Diagnostic Ultrasound in the US - 2013, 2019
  • Figure 9: US Overall Sales ($m) Forecast for Diagnostic Ultrasound, 2010-2019
  • Figure 10: Total Installed Base and Unit Sales of Ultrasound Systems in the US, 2010-2019
  • Figure 11: US Sales ($m) Forecast for Diagnostic Ultrasound by Segment, 2012, 2019
  • Figure 12: Decline in Average Selling Price of Ultrasound Systems in the US, 2010-2019
  • Figure 13: Company Market Share in the US, 2012
  • Figure 14: US Sales ($m) Forecast for Portable Black and White Systems, 2010-2019
  • Figure 15: US Sales ($m) Forecast for Stand-Alone Black and White Systems, 2010-2019
  • Figure 16: US Overall Sales ($m) Forecast for Portable Color Systems, 2010-2019
  • Figure 17: US Overall Sales ($m) Forecast for Stand-Alone Color Systems, 2010-2019
  • Figure 18: Primary Research Summary
  • Figure 19: Primary Research Participants Affiliation
Back to Top